Novel Agents in Neuropathic Pain, the Role of Capsaicin: Pharmacology, Efficacy, Side Effects, Different Preparations.


Journal

Current pain and headache reports
ISSN: 1534-3081
Titre abrégé: Curr Pain Headache Rep
Pays: United States
ID NLM: 100970666

Informations de publication

Date de publication:
06 Aug 2020
Historique:
entrez: 8 8 2020
pubmed: 8 8 2020
medline: 2 7 2021
Statut: epublish

Résumé

Capsaicin is a natural substance used to treat neuropathic pain because of its ability to be used in a more direct form on patients and efficiently treat their pain without the amount of side effects seen in the use of oral medications. Currently, the treatments for neuropathic pain are, control of the underlying disease process, then focused on symptomatic relief with pharmacotherapy, topical analgesics, or other interventions. When all pharmacological agents fail to relieve the pain, interventional strategies can be considered, such as neural blocks, spinal cord stimulation, and intrathecal administered medications. The response to current treatment of neuropathic pain is only modest relief of symptoms. Multiple treatment options may be attempted, while ultimately leaving patients with refractory neuropathic pain. For these reasons, a better treatment approach to neuropathic pain is greatly needed. Overall, capsaicin has great potential for becoming a first- or second-line treatment for neuropathic pain, and for becoming a therapeutic option for many other neuropathic pain-related disease states.

Identifiants

pubmed: 32761268
doi: 10.1007/s11916-020-00886-4
pii: 10.1007/s11916-020-00886-4
doi:

Substances chimiques

Analgesics 0
Capsaicin S07O44R1ZM

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Auteurs

O Morgan Hall (OM)

Department of Anesthesiology, LSU School of Medicine, New Orleans, LA, Room 656, 1542 Tulane Ave, New Orleans, LA, 70112, USA.

Alaina Broussard (A)

Department of Anesthesiology, Ochsner Medical Center, 1514 Jefferson Hwy, New Orleans, LA, 70121, USA.

Tierra Range (T)

Department of Anesthesiology, Ochsner Medical Center, 1514 Jefferson Hwy, New Orleans, LA, 70121, USA.

Michelle A Carroll Turpin (MA)

Department of Biomedical Sciences, College of Medicine, University of Houston, 4849 Calhoun Rd., Houston, TX, 77204, USA.

Savannah Ellis (S)

Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103, USA.

Victoria M Lim (VM)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA.

Elyse M Cornett (EM)

Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103, USA. ecorne@lsuhsc.edu.

Alan David Kaye (AD)

Department of Anesthesiology and Pharmacology, Toxicology, and Neurosciences, Louisiana State University School of Medicine, Shreveport, LA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH